Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers

Drug Delivery

Volumn 21, Issue 5, 2014, Pages 388-396

  Huang, Aiwen ^a,b   Su, Zhigui ^b   Li, Sai ^b   Sun, Minjie ^b   Xiao, Yanyu ^b   Ping, Qineng ^b   Deng, Yanping ^c  

^a FUZHOU GENERAL HOSPITAL   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Liposomes; N trimethyl chitosan chloride; Oligoarginines; Oral absorption enhancement; Salmon calcitonin

Indexed keywords

ARGININE DERIVATIVE; CALCIUM; CELL PENETRATING PEPTIDE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; LIPOSOME; N TRIMETHYL CHITOSAN CHLORIDE; PENETRATION ENHANCING AGENT; SALCATONIN; UNCLASSIFIED DRUG; ARGININE; CALCITONIN; CHITOSAN; DEXTRAN; DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE; N-TRIMETHYL CHITOSAN CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CACO 2 CELL LINE; CALCIUM BLOOD LEVEL; CELL MEMBRANE; CELL TRANSPORT; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PENETRATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; STATIC ELECTRICITY; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG EFFECTS; HUMAN; INTESTINE; INTESTINE ABSORPTION; INTESTINE MUCOSA; METABOLISM; ORAL DRUG ADMINISTRATION; PERMEABILITY; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANIMALS; ARGININE; CACO-2 CELLS; CALCITONIN; CELL LINE, TUMOR; CHITOSAN; DEXTRANS; DRUG CARRIERS; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; INTESTINES; LIPOSOMES; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84905026385     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.848247     Document Type: Article

References (21)

1. Chu-Kung AF, Bozzelli KN, Lockwood NA, et al. (2004). Promotion of peptide antimicrobial activity by fatty acid conjugation. Bioconjug Chem 15:530-5. (Pubitemid 38657858)
2. Di Colo G, Burgalassi S, Zambito Y, et al. (2004). Effects of different N-trimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation. J Pharm Sci 93:2851-62. (Pubitemid 39506634)
3. Goldberg M, Gomez-Orellana I. (2003). Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov 2:289-95. (Pubitemid 37361687)
4. Guzey D, McClements DJ. (2006). Formation, stability and properties of multilayer emulsions for application in the food industry. Adv Colloid Interface Sci 128-130:227-48. (Pubitemid 46215533)
5. Hearnden V, Sankar V, Hull K, et al. (2012). New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev 64:16-28.
6. Huang A, Makhlof A, Ping Q, et al. (2011). N-trimethyl chitosanmodified liposomes as carriers for oral delivery of salmon calcitonin. Drug Deliv 18:562-9.
7. Jin XF, Xu Y, Shen J, et al. (2011). Chitosan-glutathione conjugatecoated poly(butyl cyanoacrylate) nanoparticles: promising carriers for oral thymopentin delivery. Carbohydr Polym 86:51-7.
8. Khafagy E, Morishita M. (2012). Oral biodrug delivery using cellpenetrating peptide. Adv Drug Deliv Rev 64:531-9.
9. Kotzé AF, de Leeuw BJ, Lue En HL, et al. (1997). Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers. Int J Pharm 159: 243-53. (Pubitemid 28055860)
10. Makhlof A, Fujimoto S, Tozuka Y, Takeuchi H. (2010). In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery. Eur J Pharm Biopharm 77:216-24.
11. Makhlof A, Werle M, Tozuka Y, Takeuchi H. (2011). A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. J Control Release 149:81-8.
12. Mohammed AF, Abdul-Wahid A, Huang EH, et al. (2012). The Pseudomonas aeruginosa exotoxin A translocation domain facilitates the routing of CPP-protein cargos to the cytosol of eukaryotic cells. J Control Release 164:58-64.
13. Sadeghi AM, Dorkoosh FA, Avadi MR, et al. (2008). Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur J Pharm Biopharm 70:270-8.
14. Sajeesh S, Bouchemal K, Marsaud V, et al. (2010). Cyclodextrin complexed insulin encapsulated hydrogel microparticles: an oral delivery system for insulin. J Control Release 147:377-84.
15. Sakuma S, Suita M, Yamamoto T, et al. (2012). Performance of cellpenetrating peptide-linked polymers physically mixed with poorly membrane-permeable molecules on cell membranes. Eur J Pharm Biopharm 81:64-73.
16. Takeuchi H, Matsui Y, Sugihara H, et al. (2005). Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm 303:160-70. (Pubitemid 41318033)
17. Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y. (2003). Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release 86:235-42. (Pubitemid 36084273)
18. van der Merwe SM, Verhoef JC, Kotze AF, Junginger HE. (2004a). N-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery. Development and characterization of minitablet and granule formulations. Eur J Pharm Biopharm 57:85-91. (Pubitemid 38058806)
19. van der Merwe SM, Verhoef JC, Verheijden JH, et al. (2004b).Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm 58:225-35. (Pubitemid 39037231)
20. Werle M, Makhlof A, Takeuchi H. (2010). Carbopol-lectin conjugate coated liposomes for oral peptide delivery. Chem Pharm Bull (Tokyo) 58:432-4.
21. Zaro JL, Shen WC. (2003). Quantitative comparison of membrane transduction and endocytosis of oligopeptides. Biochem Biophys Res Commun 307:241-7. (Pubitemid 36818860)